Grifols is a global healthcare company that since its founding in Barcelona in 1909 has enhanced the health and well-being of people around the world. Our four divisions – Bioscience, Diagnostic, Hospital, and Bio Supplies – develop, produce, and market innovative solutions and services in more than 100 countries.
As a recognized leader in transfusion medicine, the Diagnostic division shares the commitment to increase transfusion safety from donation to transfusion. The division offers a comprehensive portfolio while helping to manage and simplify laboratory operations. Additionally, the division offers a portfolio of specialized clinical diagnostics focused on select therapeutic areas.
Grifols, with more than 24,000 employees in 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety, and ethical leadership in the industry.
For more information, visit www.grifols.com